Next 10 |
home / stock / ciii.p:cc / ciii.p:cc news
(TheNewswire) Winnipeg – TheNewswire - June 27, 2024 - Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “ Company ”), the only publicly traded phage company that is focused on bacteriophage solutions for...
(TheNewswire) Winnipeg – TheNewswire - June 20, 2024 - Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both anim...
(TheNewswire) Winnipeg, June 4, 2024. - TheNewswire - Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal healt...
(TheNewswire) Winnipeg – TheNewswire - May 30, 2024. Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal...
(TheNewswire) Winnipeg, May 27, 2024. Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, ...
(TheNewswire) Winnipeg, April 30, 2024. Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health...
(TheNewswire) Winnipeg – TheNewswire - April 16, 2024. Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”) is pleased to announce that Michael D. Cochrane, a managing partner at Dixford Capital, LLC, h...
(TheNewswire) Winnipeg – TheNewswire - [April 2nd, 2024]. Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”) is pleased to provide an interim update on the recently completed human trial at The ...
(TheNewswire) Winnipeg – TheNewswire - March 1 , 2024 — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV:CYTO) is pleased to announce that it is collaborating with infectious diseases clinician-scientist, Dr. Marisa A...
(TheNewswire) Winnipeg – TheNewswire - February 12, 2024 - Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”) is pleased to announced that it has completed research and development of its OvaPhage product, and is preparing to conduc...
News, Short Squeeze, Breakout and More Instantly...
Cuspis Capital Iii Ltd. Company Name:
CIII.P:CC Stock Symbol:
TSXVC Market:
(TheNewswire) Winnipeg – TheNewswire - June 27, 2024 - Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “ Company ”), the only publicly traded phage company that is focused on bacteriophage solutions for...
(TheNewswire) Winnipeg – TheNewswire - June 20, 2024 - Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both anim...
(TheNewswire) Winnipeg, June 4, 2024. - TheNewswire - Cytophage Technologies Ltd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal healt...